down arrow

Jagsonpal Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE048B01035
  • NSEID: JAGSNPHARM
  • BSEID: 507789
INR
209.40
-8.75 (-4.01%)
BSENSE

Dec 05

BSE+NSE Vol: 61.11 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Venus Remedies
Bliss GVS Pharma
Shukra Pharma.
Syncom Formul.
Windlas Biotech
Lincoln Pharma.
Jagsonpal Pharma
Bajaj Healthcare
Sigachi Indust.
Hester Bios
Beta Drugs Ltd
Why is Jagsonpal Pharmaceuticals Ltd ?
1
With ROE of 17, it has a Very Expensive valuation with a 5.5 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -25.21%, its profits have risen by 60.3% ; the PEG ratio of the company is 0.6
2
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
3
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 2.12% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -25.21% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jagsonpal Pharma for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Jagsonpal Pharma
-25.21%
-0.46
54.87%
Sensex
4.83%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.12%
EBIT Growth (5y)
35.17%
EBIT to Interest (avg)
31.03
Debt to EBITDA (avg)
0.30
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
1.31
Tax Ratio
21.23%
Dividend Payout Ratio
58.85%
Pledged Shares
0
Institutional Holding
2.21%
ROCE (avg)
36.15%
ROE (avg)
16.16%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
33
Industry P/E
34
Price to Book Value
5.53
EV to EBIT
27.28
EV to EBITDA
22.60
EV to Capital Employed
12.18
EV to Sales
4.42
PEG Ratio
0.55
Dividend Yield
1.19%
ROCE (Latest)
44.66%
ROE (Latest)
16.98%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
PBDIT(Q)

Highest at Rs 16.44 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 22.08%

PBT LESS OI(Q)

Highest at Rs 13.78 cr.

PAT(Q)

At Rs 12.57 cr has Grown at 20.3% (vs previous 4Q average

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Jagsonpal Pharma
Operating Profit (PBDIT) - Quarterly
Highest at Rs 16.44 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 22.08%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 13.78 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 13.78 cr has Grown at 23.5% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 11.16 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 12.57 cr has Grown at 20.3% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 10.45 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Jagsonpal Pharma
Non Operating Income - Quarterly
Highest at Rs 3.03 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."